Atlas Trials

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Clinical trial NCT04840758 · UNKNOWN

Trial details

NCT number
NCT04840758
Sponsor
The First Affiliated Hospital of Xiamen University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Primary Lung Cancer
Start date
2021-06-01
Primary completion
2022-12-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.